欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/0840/004
药品名称
ALTHYXIN
活性成分
levothyroxine sodium 100.0 µg
剂型
Tablet
上市许可持有人
Zentiva k.s. U kabelovny 130 10237 Praha 10 CZ
参考成员国 - 产品名称
Czechia (CZ)
ALTHYXIN
互认成员国 - 产品名称
Netherlands (NL)
Levothyroxine Abdi 100 microgram tabletten
Poland (PL)
许可日期
2019/11/06
最近更新日期
2024/02/28
药物ATC编码
H03AA01 levothyroxine sodium
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
PI
Date of last change:2024/02/09
Final PL
|
levothyroxine CZ_H_0840_001-8 name change 16062020 cl
Date of last change:2020/07/31
PAR
|
CZ_0840_001-8_DC_PAR
Date of last change:2020/05/20
Final SPC
|
131-common-spc_clean
Date of last change:2020/03/13
Final Labelling
|
131-common-interpack-clean
Date of last change:2019/11/28
Final Labelling
|
131-common-outer-clean
Date of last change:2019/11/28
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase